Article
Novel single nucleotide polymorphisms in interleukin 6 affect tacrolimus metabolism in liver transplant patients.
PloS one - 1 Jan 2013
Chen Dawei, Fan Junwei, Guo Feng, Qin Shengying, Wang Zhaowen, Peng Zhihai
Abstract excerpt
BACKGROUND: Tacrolimus is the first-line immunosuppressant after organ transplantation. It is mainly metabolized by cytochrome P450, family 3, subfamily A (CYP3A) enzymes, but there are large individual differences in metabolism. Interleukin 6 (IL6) has been shown to cause a pan-suppression of mRNA levels of ten major CYP enzymes in human hepatocyte cultures. IL6 has been shown to provide hepatoprotection in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
